Vaxcyte Inc (PCVX) — Defensive Interval Ratio

Latest as of March 2026: 2226 days

Vaxcyte Inc (PCVX) has a Defensive Interval Ratio of 2226 days as of March 2026. Defensive assets of $1.48 Billion (cash $-, short-term investments $1.48 Billion, receivables $-) cover 2226 days of daily cash needs of $663.24K/day. Check Vaxcyte Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

2226 days
Days of operational coverage

Defensive Assets

$1.48 Billion
Cash + ST Investments + Receivables

Daily Cash Need

$663.24K
Current Liabilities ÷ 365

Current Liabilities

$242.08 Million
USD

Vaxcyte Inc Defensive Interval Ratio (2019–2025)

This chart shows how Vaxcyte Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 2226 days, meaning defensive assets of $1.48 Billion can fund 2226 days of operations without new revenue. Also explore PCVX shareholders equity momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Vaxcyte Inc (2019–2025)

The table below presents the year-by-year Defensive Interval Ratio for Vaxcyte Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see PCVX company net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 2543 days $1.43 Billion $563.70K/day $- $1.39 Billion ▼ -1050 days
2024 3593 days $1.38 Billion $384.05K/day $- $1.36 Billion ▲ +1869 days
2023 1724 days $686.38 Million $398.19K/day $- $682.78 Million ▲ +844 days
2022 880 days $97.72 Million $111.03K/day $- $96.72 Million ▼ -1385 days
2021 2265 days $178.19 Million $78.67K/day $- $176.99 Million ▲ +2263 days
2020 2 days $300.00K $128.39K/day $- $0.00 ▼ -4 days
2019 7 days $200.00K $30.28K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)